PHAT- Phathom Pharmaceuticals, Inc.

Name: Phathom Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Phathom Pharmaceuticals, Inc. (PHAT) has 5 insiders with recent SEC Form 4 filings, including 5 buys and 8 sells. PHAT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Basta Steven L	373.3K	$3.99M	-
CFO	Narula Sanjeev	226.7K	$2.42M	-
Other	Cook Anne Marie	90.2K	$964.2K	-
Other	Breedlove Robert Charles	47.8K	$511.5K	-
Dir	Parikh Asit	10.5K	$112.2K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 22, 2024	Curran Terrie68	President And Chief Executive	Sell	16,851	$9.11	$153,512.61	-3.9%	+7.2%	-43.5%
Jan 19, 2024	Henderson Molly52	CFO And Cbo	Sell	6,307	$7.75	$48,900.06	-6.0%	+26.6%	-7.1%
Nov 20, 2023	Henderson Molly52	CFO And Cbo	Sell	2,127	$7.24	$15,402.67	-2.0%	+37.2%	+26.5%
Nov 8, 2023	Parikh Asit87	Director	Buy	7,500	$7.81	$58,580.00	+5.1%	-9.5%	+136.6%
Nov 1, 2023	Henderson Molly52	CFO And Cbo	Sell	12,492	$8.88	$110,870.75	-5.3%	-28.9%	+78.5%
Jun 2, 2023	Henderson Molly52	CFO And Cbo	Sell	1,960	$11.41	$22,367.72	-2.8%	+23.4%	-19.2%
May 22, 2023	Henderson Molly52	CFO And Cbo	Sell	2,110	$12.87	$27,164.98	-2.9%	+11.6%	-20.4%
Apr 11, 2023	Nabulsi Azmi74	Chief Operating Officer	Buy	10,000	$8.26	$82,600.00	+11.2%	+69.8%	+43.4%
Apr 10, 2023	Parikh Asit87	Director	Buy	1,000	$7.55	$7,550.00	+4.4%	+73.4%	+49.5%
Apr 6, 2023	Henderson Molly52	CFO And Cbo	Sell	3,439	$7.27	$25,001.53	-4.5%	+77.7%	+43.2%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC